Reuters logo
BRIEF-Pharnext: ‍Successful Intermediate Analyses For Pleo-Cmt Phase III Clinical Trial
November 29, 2017 / 5:37 PM / 16 days ago

BRIEF-Pharnext: ‍Successful Intermediate Analyses For Pleo-Cmt Phase III Clinical Trial

Nov 29 (Reuters) - PHARNEXT SAS:

* ‍SUCCESSFUL INTERMEDIATE ANALYSES FOR PLEO-CMT PHASE III CLINICAL TRIAL IN CHARCOT-MARIE-TOOTH DISEASE TYPE 1A​

* ‍PLEO-CMT STUDY TO CONTINUE AS PLANNED WITHOUT INCREASING NUMBER OF PATIENTS​

* ANALYSUS ALLOW CO TO CONFIRM SCHEDULE FOR FINAL RESULTS BY SECOND HALF OF 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below